AptarGroup, Inc. ATR
Composite 53/100; the shares have moved about 24% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Valuation ranks 46/100 — a slight mark against it.
Balance-sheet strength ranks 68/100 — a moderate point in its favour. Income ranks 54/100 — a slight point in its favour. Quality ranks 53/100 — a slight point in its favour.
Valuation ranks 46/100 — a slight mark against it. Growth ranks 47/100 — a slight mark against it. Momentum ranks 48/100 — a slight mark against it.
What the company does AptarGroup designs and manufactures drug-delivery systems, dispensing pumps, closures, and active-material solutions for pharmaceuticals, beauty, and consumer markets across Asia, Europe, and the Americas.
Key financials Aptar posts gross margin 37%, operating margin 11%, and net margin 10%. ROE is 15%, ROA 7%, ROCE 13%. Revenue grew 11% while EPS fell 4%. Debt/equity is 0.51 with interest coverage 9.21 and current ratio 1.61.
Stock health Momentum shows 3m +9%, 6m +9%, 12m –14%, and RSI 61. Sideravia scores Valuation 51 (fair value), Quality 48 (average), Growth 34 (below average), Strength 70 (above average).
Price vs fair value The stock trades at a PREMIUM of 46.30% to our fair-value estimate of 71.51 and a discount of 24.12% to the analyst 12-month target of 165.43. - Q2 results topped earnings and revenue estimates (Zacks) - Earnings call highlighted growth drivers (MarketBeat) - Simply Wall St. argues the stock could be below fair value after a 15% fall (Simply Wall St.)
Looking forward Forward P/E is 17.15 and PEG 0.53, implying undemanding valuation if growth resumes. Analysts target 165.43 over 12 months, suggesting 24% upside from the current price.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.